PIPA584365

FAM193B Polyclonal Antibody, Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 PIPA584365-Each-of-1 In Stock ₹ 48,905.50

PIPA584365 - Each of 1

₹ 48,905.50

In Stock

Quantity

1

Base Price: ₹ 48,905.50

GST (18%): ₹ 8,802.99

Total Price: ₹ 57,708.49

Antigen

FAM193B

Classification

Polyclonal

Conjugate

Unconjugated

Gene

FAM193B

Gene Alias

FAM193B; family with sequence similarity 193 member B; IRIZIO; KIAA1931; Protein FAM193B

Host Species

Rabbit

Purification Method

Anitgen affinity chromatography, Antigen affinity chromatography

Regulatory Status

RUO

Gene ID (Entrez)

54540

Content And Storage

Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.

Form

Liquid

Applications

Immunocytochemistry

Concentration

0.1 mg/mL

Formulation

PBS with 40% glycerol and 0.02% sodium azide; pH 7.2

Gene Accession No.

Q96PV7

Gene Symbols

FAM193B

Immunogen

Recombinant protein corresponding to Human FAM193B

Quantity

100 μL

Primary or Secondary

Primary

Target Species

Human

Product Type

Antibody

Isotype

IgG

Related Products

Img

Thermo Scientific

PIPA584396

--

Img

Thermo Scientific

PIPA584379

--

Img

Thermo Scientific

PIPA558529

--

Img

Thermo Scientific

PIPA584389

--

Img

Thermo Scientific

PIPA584663

--

Img

Thermo Scientific

PIPA584441

--

Img

Thermo Scientific

PIPA584581

--

Img

Thermo Scientific

PIPA558434

--

Description

  • Immunogen sequence: NTVPNLSRVI WVKTPKPGYP SSEEPSSKEV PSCKQELPEP VSSGGKPQKG KRQGSQAKKS EASPAPRPPA SLEVPSAKGQ VAGPKQ FAM193B, also known as IRIZIO, was initially identified as a protein that is upregulated in alveolar rhabdomyosarcoma (ARMS), a type of fast-growing tumor characterized by chromosomal translocations fusing the PAX3 or PAX7 gene with that of FOXO1
  • It has been suggested that, in addition to the PAX3-FOXO1 gene fusion, disruption of the Rb and p53 pathways is required for full ARMS tumorigenesis
  • In PAX3-FOXO1-expressing primary mouse fibroblasts that possessed a defective p53 pathway, FAM193B expression enabled the tumorigenic transformation, suggesting that FAM193B may contribute to rhabdomyosarcomagenesis in humans.